Prospective multicentre study of the U-SENS test method for skin sensitization testing.

Area of Science:

• Toxicology
• In vitro methods
• Dermatology

Background:

• Skin sensitization is a significant health concern.
• Non-animal testing methods are increasingly important for regulatory assessments.
• The U-SENS™ assay utilizes the human myeloid U937 cell line.

Purpose of the Study:

• To validate the robustness and reproducibility of the U-SENS™ skin sensitization test method.
• To assess the transferability and predictive capability of the U-SENS™ assay.
• To expand the reproducibility database for the U-SENS™ method.

Main Methods:

• A multicentre validation study involving four laboratories.
• Testing of 24 coded substances according to international principles.
• Statistical analysis of intra-laboratory and inter-laboratory reproducibility.

Main Results:

• High intra-laboratory reproducibility (approx. 92%) and inter-laboratory reproducibility (87.5%).
• Excellent predictive performance for 24 substances: sensitivity, specificity, and accuracy averaged at least 93.8%.
• Consistent performance when combined with previous study data and an automated U-SENS™ version.

Conclusions:

• The U-SENS™ method is a well-reproducible and predictive non-animal test for skin sensitization.
• Its performance is comparable to other regulatory-accepted non-animal methods.
• U-SENS™ is a valuable tool for integrated testing strategies in skin sensitization assessment.